Rituximab in severe skin diseases: target, disease, and dose
Clinical Pharmacology: Advances and Applications · 2010
DOI: 10.2147/cpaa.s10929 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Pharmacology: Advances and Applications, 2010. Verfasst von Daniel D Bennett und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Division of Hematology and Oncology, Scott and White Healthcare, Texas A&M Health Science Center College of Medicine. Temp…. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Division of Hematology and Oncology, Scott and White Healthcare, Texas A&M Health Science Center College of Medicine. Temple, TX, USA.
Zitieren
APA
Bennett, D. D., Ohanian, M., & Cable, C. T. (2010). Rituximab in severe skin diseases: target, disease, and dose. Clinical Pharmacology: Advances and Applications. https://doi.org/10.2147/cpaa.s10929
Vancouver
Bennett DD, Ohanian M, Cable CT. Rituximab in severe skin diseases: target, disease, and dose. Clinical Pharmacology: Advances and Applications. 2010. doi:10.2147/cpaa.s10929
BibTeX
@article{Bennett2010,
author = {Bennett, Daniel D and Ohanian, Maro and Cable, Christian T},
title = {Rituximab in severe skin diseases: target, disease, and dose},
journal = {Clinical Pharmacology: Advances and Applications},
year = {2010},
doi = {10.2147/cpaa.s10929}
}
EUVIMED